US Stocks
/
Summit Therapeutics Inc. Share Price

Summit Therapeutics Inc. Share Price

NASDAQ: SMMT | Large Cap
$13.96
+$0.42 (3.10%) Last updated on 08 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Summit Therapeutics Inc. Stock Performance

Open
$13.85
Prev. Close
$13.54
Circuit Range
N/A
Day Range
$13.52 - $14.02
Year Range
$12.25 - $30.00
Volume
90,769
Average Traded
$13.89

Summit Therapeutics Inc. Share Price Today

As of 10 August 2026, Summit Therapeutics Inc.'s share price is $13.96. The stock opened at $13.85, compared to its previous close of $13.54. During today's trading session, Summit Therapeutics Inc.'s share price traded between $13.52 and $14.02, with an average price of $13.77. Over the past 52 weeks, the stock has recorded a high of $30.00 and a low of $12.25. In terms of performance, Summit Therapeutics Inc.'s share price has declined by 15.93% over the last six months and is down 41.19% on a year-on-year basis.

Summit Therapeutics Inc. Share Price Chart

$13.52$14.02
L
Show Current Price
H

Summit Therapeutics Inc. Stock Fundamentals & Key Indicators

Market Cap
$10.43B
PE Ratio (TTM)
-9.69
Dividend Yield
N/A
EPS (TTM)
$-1.44
Revenue (TTM)
N/A
Return On Equity (TTM)
-163.86%
Profit Margin
N/A
Debt to Equity
0.11
Quarterly Earnings Growth YoY
N/A

Summit Therapeutics Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2024
Revenue$0.00
Net Profit-$56.25M
Net Profit MarginN/A
Income ChangeN/A

Summit Therapeutics Inc. Annual Profit & Loss

All figures in USD

Particulars20232024
Revenue$0.00$0.00
Net Profit-$614.93M-$221.31M
Net Profit MarginN/AN/A
Income ChangeN/A64.01%

About Summit Therapeutics Inc.

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis, as well as in Phase III clinical trials for the treatment of non-small lung cancer. The company was founded in 2003 and is headquartered in Miami, Florida.

Summit Therapeutics Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$13.07
$13.96
+7.18%
Jul 2026
$14.54
$13.02
-10.64%
Jun 2026
$16.72
$14.57
-16.89%
May 2026
$16.02
$17.53
-18.33%
Apr 2026
$19.17
$21.46
+13.27%
Mar 2026
$16.16
$18.95
+14.16%
Feb 2026
$14.24
$16.60
+14.72%
Jan 2026
$17.66
$14.47
-17.29%
Dec 2025
$17.36
$17.50
-2.15%
Nov 2025
$18.86
$17.88
-5.40%
Oct 2025
$20.75
$18.90
-8.52%
Sep 2025
$23.18
$20.66
-12.94%

SMMT Share Price FAQs

What is Summit Therapeutics Inc. share price today?

chevron-up
Summit Therapeutics Inc. share price today is $13.96 as on August 8, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Summit Therapeutics Inc. stock?

chevron-up
The 52 week high of Summit Therapeutics Inc. stock is $30.00, while the 52 week low is $12.25 as of 8 Aug '26.

What is SMMT's market capitalisation today?

chevron-up
SMMT market capitalisation is $10.43B as of August 10, 2026, at 1:37 pm IST.

What is SMMT's net income for the last quarter?

chevron-up
SMMT's net income for the last quarter is -0.06B USD.

What is the 5 year returns of SMMT?

chevron-up
The 5 year returns of SMMT is 75.09% as on 8 Aug '26.

What is the high & low stock price of SMMT today?

chevron-up
SMMT stock price hit a high of $14.02 and low of $13.52 as of 8 Aug '26.

Can I buy SMMT shares in India?

chevron-up
Yes. You can buy SMMT in India by opening an international trading account.